M. Bonnay

2.0k total citations
37 papers, 1.5k citations indexed

About

M. Bonnay is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, M. Bonnay has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in M. Bonnay's work include Cancer therapeutics and mechanisms (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). M. Bonnay is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). M. Bonnay collaborates with scholars based in France, Germany and United States. M. Bonnay's co-authors include Michel Ducreux, D. Élias, Gilles Vassal, A. El Otmany, S. Antoun, Lewis S. Freedman, M. Goldstein, Martin Schlumberger, Eric Baudin and Jean‐Pierre Pignon and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

M. Bonnay

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Bonnay France 19 725 411 275 244 238 37 1.5k
Olatunji B. Alese United States 22 770 1.1× 1.3k 3.1× 350 1.3× 124 0.5× 300 1.3× 149 2.1k
Serge Évrard France 27 810 1.1× 745 1.8× 323 1.2× 209 0.9× 220 0.9× 128 2.2k
Sylvia Stadlmann Austria 25 429 0.6× 502 1.2× 610 2.2× 16 0.1× 229 1.0× 56 2.0k
Kazuyasu Nakao Japan 23 861 1.2× 640 1.6× 609 2.2× 39 0.2× 210 0.9× 91 1.8k
Wook‐Hwan Kim South Korea 25 931 1.3× 599 1.5× 528 1.9× 76 0.3× 123 0.5× 57 1.8k
R. L. Marquet Netherlands 24 728 1.0× 736 1.8× 310 1.1× 28 0.1× 139 0.6× 100 1.9k
Bernard Royer France 16 358 0.5× 241 0.6× 275 1.0× 50 0.2× 49 0.2× 68 1.2k
Hans G. Beger Germany 22 1.6k 2.2× 1.4k 3.4× 578 2.1× 83 0.3× 134 0.6× 33 2.5k
Sotaro Sadahiro Japan 27 1.1k 1.5× 1.6k 4.0× 539 2.0× 73 0.3× 321 1.3× 194 2.8k
Anne Durnez Belgium 14 436 0.6× 346 0.8× 579 2.1× 164 0.7× 327 1.4× 21 1.8k

Countries citing papers authored by M. Bonnay

Since Specialization
Citations

This map shows the geographic impact of M. Bonnay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Bonnay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Bonnay more than expected).

Fields of papers citing papers by M. Bonnay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Bonnay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Bonnay. The network helps show where M. Bonnay may publish in the future.

Co-authorship network of co-authors of M. Bonnay

This figure shows the co-authorship network connecting the top 25 collaborators of M. Bonnay. A scholar is included among the top collaborators of M. Bonnay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Bonnay. M. Bonnay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Élias, D., Bruno Raynard, M. Bonnay, & Marc Pocard. (2006). Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies. European Journal of Surgical Oncology. 32(6). 607–613. 42 indexed citations
2.
Bonvalot, Sylvie, M. Bonnay, L. Drouard-Troalen, et al.. (2006). Pressure-suit combined with pelvic stop-flow: A feasibility study in a bovine model. European Journal of Surgical Oncology. 33(1). 114–118. 3 indexed citations
3.
Nader, Nader D., Gérald Raverot, Agnès Emptoz-Bonneton, et al.. (2006). Mitotane Has an Estrogenic Effect on Sex Hormone-Binding Globulin and Corticosteroid-Binding Globulin in Humans. The Journal of Clinical Endocrinology & Metabolism. 91(6). 2165–2170. 59 indexed citations
4.
Delbaldo, Catherine, Jean‐Yves Pierga, Véronique Dièras, et al.. (2005). Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma. European Journal of Cancer. 41(12). 1739–1745. 71 indexed citations
5.
Džodić, Radan, Gonzalo Gomez-Abuin, Philippe Rougier, et al.. (2004). Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model. Anti-Cancer Drugs. 15(6). 647–650. 70 indexed citations
6.
Élias, D., M. Bonnay, S. Antoun, et al.. (2002). Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Annals of Oncology. 13(2). 267–272. 281 indexed citations
7.
Élias, D., A. El Otmany, M. Bonnay, et al.. (2002). Human Pharmacokinetic Study of Heated Intraperitoneal Oxaliplatin in Increasingly Hypotonic Solutions after Complete Resection of Peritoneal Carcinomatosis. Oncology. 63(4). 346–352. 73 indexed citations
8.
Čemažar, Maja, Damijan Miklavčič, Lluis M. Mir, et al.. (2001). Electrochemotherapy of tumours resistant to cisplatin. European Journal of Cancer. 37(9). 1166–1172. 35 indexed citations
9.
Baudin, Eric, Gabriella Pellegriti, M. Bonnay, et al.. (2001). Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer. 92(6). 1385–1392. 172 indexed citations
10.
Kępka, Lucyna, Arnaud de Lassence, Vincent Ribrag, et al.. (1998). Successful Rescue in a Patient with High Dose Methotrexate-Induced Nephrotoxicity and Acute Renal Failure. Leukemia & lymphoma. 29(1-2). 205–209. 17 indexed citations
11.
Saliba, Faouzi, J. L. Misset, G. Bastian, et al.. (1998). Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.. Journal of Clinical Oncology. 16(8). 2745–2751. 112 indexed citations
12.
Bonacci, R, Anna Rita Gigliotti, Eric Baudin, et al.. (1998). Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. British Journal of Cancer. 78(4). 546–549. 60 indexed citations
13.
Chabot, G G, Jean‐Pierre Armand, C. Terret, et al.. (1996). Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.. Journal of Clinical Oncology. 14(7). 2020–2030. 23 indexed citations
14.
Valteau-Couanet, D, Gilles Vassal, Corinne Pondarré, et al.. (1996). Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.. PubMed. 17(4). 485–9. 5 indexed citations
15.
Juliéron, M., et al.. (1995). Stimulation of tumor growthin vitro andin vivo by suramin on the VX2 model. Investigational New Drugs. 13(1). 51–53. 18 indexed citations
16.
Parise, Orlando, François Janot, B Luboïnski, et al.. (1994). Thymidylate synthase activity, folates, and glutathione system in head and neck carcinoma and adjacent tissues. Head & Neck. 16(2). 158–164. 13 indexed citations
17.
Droz, Jean‐Pierre, et al.. (1993). High-dose continuous-infusion fosfestrol in hormone-resistant prostate cancer. Cancer. 71(S3). 1123–1130. 22 indexed citations
18.
Dubray, Bernard, Howard D. Thames, Aldo Becciolini, et al.. (1992). Post-irradiation hyperamylasemia as a biological dosimeter. Radiotherapy and Oncology. 24(1). 21–26. 30 indexed citations
19.
Vassal, Gilles, et al.. (1990). Cerebrospinal Fluid and Plasma Methotrexate Levels Following High-Dose Regimen Given as a 3-Hour Intravenous Infusion in Children with Nonhodgkin's Lymphoma. Pediatric Hematology and Oncology. 7(1). 71–77. 27 indexed citations
20.
Lespinasse, Françoise, et al.. (1989). Ro 03-8799: Preferential relative uptake in human tumor xenografts compared to a murine tumor: Comparison with SR-2508. International Journal of Radiation Oncology*Biology*Physics. 16(4). 1105–1109. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olatunji B. Alese Breakdown of academic impact, for papers by Serge Évrard Breakdown of academic impact, for papers by Sylvia Stadlmann Breakdown of academic impact, for papers by Kazuyasu Nakao Breakdown of academic impact, for papers by Wook‐Hwan Kim Breakdown of academic impact, for papers by R. L. Marquet Breakdown of academic impact, for papers by Bernard Royer Breakdown of academic impact, for papers by Hans G. Beger Breakdown of academic impact, for papers by Sotaro Sadahiro Breakdown of academic impact, for papers by Anne Durnez
Rankless by CCL
2026